
GC11264
CNX-2006
Also known as N-[3-[[2-[4-[[1-(2-fluoroethyl)azetidin-3-yl]amino]-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide
mutant-EGFR inhibitor, selective and irreversible
ChemicalCAS1375465-09-0MW545.53FormulaC26H27F4N7O2
- CAS number
- 1375465-09-0
- Molecular weight
- 545.53
- Formula
- C26H27F4N7O2
- Solubility
- ≥ 27·3mg/mL in DMSO
- InChIKey
- BFSRTTWIPACGMI-UHFFFAOYSA-N
- Catalogue number
- GC11264
- Brand
- GLPBIO
Computed properties PubChem CID 56968072 · XLogP 4.8 · TPSA 103 Ų · H-bond donors 4
- XLogP
- 4.8
- TPSA
- 103 Ų
- H-bond donors
- 4
- H-bond acceptors
- 12
- Rotatable bonds
- 11
- Heavy atoms
- 39
SMILES COC1=C(C=CC(=C1)NC2CN(C2)CCF)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F
Computed descriptors from PubChem (CID 56968072), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il